Cwm LLC Invests $251,000 in Revvity, Inc. (NYSE:RVTY)

Cwm LLC acquired a new position in shares of Revvity, Inc. (NYSE:RVTY) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 2,295 shares of the company’s stock, valued at approximately $251,000.

Several other institutional investors and hedge funds have also made changes to their positions in the stock. Gladius Capital Management LP lifted its stake in shares of Revvity by 84.1% during the third quarter. Gladius Capital Management LP now owns 232 shares of the company’s stock worth $26,000 after buying an additional 106 shares during the period. CENTRAL TRUST Co acquired a new position in Revvity during the fourth quarter valued at $27,000. ORG Partners LLC acquired a new position in Revvity during the fourth quarter valued at $32,000. JTC Employer Solutions Trustee Ltd acquired a new position in Revvity during the fourth quarter valued at $33,000. Finally, Desjardins Global Asset Management Inc. acquired a new position in Revvity during the fourth quarter valued at $37,000. 86.65% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Revvity

In related news, insider Prahlad R. Singh sold 21,217 shares of the company’s stock in a transaction dated Monday, February 5th. The shares were sold at an average price of $104.28, for a total transaction of $2,212,508.76. Following the completion of the sale, the insider now owns 92,801 shares of the company’s stock, valued at approximately $9,677,288.28. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 0.60% of the stock is owned by corporate insiders.

Analyst Ratings Changes

A number of research analysts recently issued reports on the stock. TD Cowen boosted their target price on shares of Revvity from $123.00 to $130.00 and gave the company a “buy” rating in a research report on Tuesday. Barclays boosted their target price on shares of Revvity from $92.00 to $105.00 and gave the company an “equal weight” rating in a research report on Thursday, January 25th. KeyCorp lifted their price objective on shares of Revvity from $110.00 to $126.00 and gave the company an “overweight” rating in a report on Friday, February 2nd. Raymond James lifted their price objective on shares of Revvity from $106.00 to $127.00 and gave the company an “outperform” rating in a report on Friday, February 2nd. Finally, UBS Group cut shares of Revvity from a “buy” rating to a “neutral” rating and lifted their price objective for the company from $105.00 to $125.00 in a report on Tuesday, January 16th. Six analysts have rated the stock with a hold rating and seven have given a buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $118.17.

Revvity Stock Down 0.5 %

RVTY stock opened at $100.61 on Friday. The stock has a market capitalization of $12.43 billion, a P/E ratio of 83.15, a P/E/G ratio of 2.67 and a beta of 1.09. The firm has a 50-day simple moving average of $104.56 and a 200-day simple moving average of $101.28. The company has a quick ratio of 1.77, a current ratio of 2.23 and a debt-to-equity ratio of 0.40. Revvity, Inc. has a 52 week low of $79.50 and a 52 week high of $132.54.

Revvity (NYSE:RVTY) last released its earnings results on Monday, April 29th. The company reported $0.98 EPS for the quarter, topping analysts’ consensus estimates of $0.94 by $0.04. The business had revenue of $649.90 million during the quarter, compared to analysts’ expectations of $646.83 million. Revvity had a net margin of 5.49% and a return on equity of 7.37%. The company’s quarterly revenue was down 3.7% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.01 earnings per share. Equities analysts forecast that Revvity, Inc. will post 4.65 earnings per share for the current fiscal year.

Revvity Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, August 9th. Investors of record on Friday, July 19th will be paid a dividend of $0.07 per share. The ex-dividend date is Friday, July 19th. This represents a $0.28 annualized dividend and a yield of 0.28%. Revvity’s dividend payout ratio is presently 23.14%.

Revvity Company Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.